Medtech startup RenovaCare has developed a device to spray stem cells on burn injuries in an effort to regrow new skin. Here's the latest on the company's progress.
MIT researchers have developed a novel system for manufacturing biopharmaceutical drugs on demand in resource-limited environments. Kristopher Sturgis Researchers from MIT have developed a novel biopharmaceutical production system that can manufacture a variety of biopharmaceutical drugs on demand...
IBSchek, a blood test, can offer a diagnosis of irritable bowel syndrome without the long wait time and high costs of the conventional exclusionary pathway.
The agency has issued draft guidance detailing its oversight of next-gen sequencing devices used to diagnose infectious diseases.
FDA has approved Abbott's companion diagnostic to detect a specific gene deletion in certain leukemia patients, part of its pairing with a drug intended to treat such populations.
In a new subanalysis, results of a blood test are found to be correlated with cardiovascular event rates, potentially offering a way to classify coronary artery disease patients by risk of future events.
Concussion symptoms aren’t always immediate, but study results have shown a particular biomarker can be found in a patient’s blood for as long as a week.
Invitae announces new panels for pediatric, rare diseases, neuromuscular, and inherited metabolic conditions, taking its coverage well beyond oncology to more than 1000 genes.
In addition to recommendations, guidance, and emergency use authorizations, FDA wants to do more to support development of Zika diagnostic tests.
A study of over 10,000 patients tested with a multigene hereditary cancer panel finds that the approach commonly spots hereditary cancer-linked gene variants that single gene tests might miss.
In recent months, genetic testing company Invitae has dramatically expanded its test menu, focusing on diagnosing disease using a broad platform.
Noted biotech investor G. Steven Burrill had been accused of embezzling $17 million. Now, a venture firm launched by Burrill is charging PwC with being complicit in the scheme. Qmed Staff G. Steven Burrill A venture firm created by Burrill & Co. is suing PwC as well as G...
The development of biologic-delivery devices requires input from the materials science, biology, chemistry, toxicology, biomedical, mechanical engineering, and other disciplines
Cells are complex structures, making them difficult to replicate in the lab. But a team of Israeli scientists have taken a step in that direction by engineering a silicon chip that can produce proteins from DNA, the most basic function of life. The system, which was designed to be relatively simple...
For some people being well isn't enough. They want to be better. That's where these biohacking devices come in.